FDA Approves Psilocybin For Binge Eating Study By Tryp Therapeutics
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company in the medical psychedelics space, announced it has received clearance from the U.S.
Psyched: Detroit Decriminalizes Psychedelics, Compass To Study Psilocybin For PTSD, Filaments Gets First-Ever FDA Approval
Detroit Decriminalizes Psychedelics
Detroit is the latest to join the growing list of U.S. cities that have decriminalized psychedelic substances.
There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Ladenburg Thalmann Initiates Coverage On Tryp Therapeutics with Buy Rating
Ladenburg Thalmann analyst Michael Higgins initiates coverage on Tryp Therapeutics (OTC:TRYPF) with a Buy rating.
Psyched: Numinus, MindMed, Cybin Reach Milestones, Harvard To Study Psychedelics Law, Michael Pollan Dives Into Mescaline
Michael Pollan’s New Book Takes A Deep Dive Into Mescaline – Will This Be A Turning Point For The Recognition And Study of Mescaline?